超短波电疗联合抗氧化及神经营养对糖尿病周围神经病变患者神经传导功能及血清细胞因子的影响被引量：9

Effect of ultrashort wave therapy combined with antioxidant and neurotrophy therapy on nerve conduction function and serum cytokines in patients with diabetic peripheral neuropathy

暂未订购

导出

摘要目的:研究超短波电疗联合抗氧化及神经营养对糖尿病周围神经病变患者神经传导功能及血清细胞因子的影响。方法:选择诊断为DPN的128例患者作为研究对象,随机分为电疗+药物组和常规药物组;治疗前及治疗后8周时,测定神经传导速度及血清中神经细胞因子、炎症细胞因子的含量。结果:两组患者治疗后8周时正中神经及腓总神经的MNCV、正中神经及腓浅神经的SNCV以及血清中CNTF、BDNF、SDF-1α、IGF-1、CAT、HO-1的含量均显著高于治疗前,血清中ICAM-1、TNF-α、IL-6、ET-1、MDA、8-OHdG的含量均显著低于治疗前;电疗+药物组患者治疗后8周时正中神经及腓总神经的MNCV、正中神经及腓浅神经的SNCV以及血清中CNTF、BDNF、SDF-1α、IGF-1、CAT、HO-1的含量均显著高于常规药物组,血清中ICAM-1、TNF-α、IL-6、ET-1、MDA、8-OHdG的含量均显著低于常规药物组。结论:超短波电疗联合抗氧化及神经营养治疗DPN能够改善神经传导功能及神经营养状态,同时能够抑制炎症反应及氧化应激反应。 Objective:To study the effect of ultrashort wave therapy combined with antioxidant and neurotrophy therapy on nerve conduction function and serum cytokines in patients with diabetic peripheral neuropathy.Methods:A total of128patients who were diagnosed with DPN in South District of Guang’anmen Hospital of China Academy of Chinese Medical Sciences between May2014and February2017were selected as the research subjects and randomly divided into electrotherapy+drug group and routine drug group;the nerve conduction velocity as well as serum levels of nerve cytokines and inflammatory cytokines were measured before treatment and8weeks after treatment.Results:MNCV of median nerve and common peroneal nerve,SNCV of median nerve and superficial peroneal nerve as well as serum CNTF,BDNF,SDF1α,IGF1,CAT and HO1levels in both groups8weeks after treatment were significantly higher than those before treatment while serum ICAM1,TNFα,IL6,ET1,MDA and8OHdG levels were significantly lower than those before treatment;MNCV of median nerve and common peroneal nerve,SNCV of median nerve and superficial peroneal nerve as well as serum CNTF,BDNF,SDF1α,IGF1,CAT and HO1levels in electrotherapy+drug group8weeks after treatment were significantly higher than those in routine drug group while serum ICAM1,TNFα,IL6,ET1,MDA and8OHdG levels were significantly lower than those in routine drug group.Conclusions:Ultrashort wave therapy combined with antioxidant and neurotrophy therapy for DPN can improve the nerve conduction function and neurotrophic state,and also inhibit the inflammatory response and oxidative stress response.

作者李乔张博谢冰昕 LI Qiao;ZHANG Bo;XIE Bing xin(Endocrinology Department, South District of Guang’anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 102618, China)

机构地区中国中医科学院广安门医院南区内分泌科

出处《海南医学院学报》 CAS 2017年第18期2499-2502,2506,共5页 Journal of Hainan Medical University

基金中国中国中医科学院广安门医院课题(y2014-05)~~

关键词糖尿病周围神经病变超短波电疗炎症反应氧化应激 Diabetic peripheral neuropathy Ultrashort wave therapy Inflammatory response Oxidative stress

分类号 R587.2 [医药卫生—内分泌]

引文网络
相关文献

参考文献1

1Jikun Wang,Ming He.Levels of serum brain-derived neurotrophic factor in Type 2 diabetes mellitus patients with and without depressive symptoms[J].Acta Biochimica et Biophysica Sinica,2015,47(2):137-138. 被引量：6

二级参考文献13

1Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006, 49: 837-845.
2Kinder LS, Kamarck TW, Baum A, Orchard TJ. Depressive symptomatology and coronary heart disease in type I diabetes mellitus: a study of possible mechanisms. Health Psycho12002, 21: 542-552.
3Noble EE, Billington CJ, Kotz CM, Wang C. The lighter side of BDNF. Am J Physiol Regullntegr Comp Physiol 2011, 300: R1053-R1069.
4Fujinami A, Ohta K, Obayashi H, Fukui M, Hasegawa G, Nakamura N, Kozai H, et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem 2008, 41: 812-817.
5Berton 0, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311: 864-868.
6Hou S}, Yen FC, Tsai Sl. Is dysfunction of the tissue plasminogen activator (tPA)-plasmin pathway a link between major depression and cardiovascular disease? Med Hypotheses 2009, 72: 166-168.
7Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005,51: 234-238.
8Zeman M, Jachymova M, Jirak R, Vecka M, Tvrzicka E, Stankova B, Zak A. Polymorphisms of genes for brain-derived neurotrophic factor, methylenetetrahydrofolate reductase, tyrosine hydroxylase, and endothelial nitric oxide synthase in depression and metabolic syndrome. Folia Biologica (Praha) 2010, 56: 19-26.
9Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Bioi Psychiatry 2008, 64: 527-532.
10Bus BA, Molendijk ML, Penninx BJ, Buitelaar }K, Kenis G, Prickaerts J, Elzinga BM, et at. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendoainol lsn.s, 36: 228-239.